Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp111 | Diabetes therapy & complications 2 | ECE2017

Hepatic effects of GLP-1 receptor agonist Liraglutide in patients with type 2 diabetes

Hayon Maria , Fernandez Marta , Maraver Silvia , Muros Teresa , Cepero Daniel , Lopez Martin , Quesada Miguel , Pechuan Joaquin , Piedrola Gonzalo

Introduction: The aim of this study was to analyze the effects of Liraglutide in hepatic steatosis as well as clinical and biochemical data before and after 6 months.Methods: We have retrospectively analysed epidemiological, anthropometric and laboratory data of 83 type 2 diabetic patients treated with Liraglutide and followed at different endocrinology units across east Andalusia. We have evaluated nonalcoholic fatty liver disease using liver enzymes an...

ea0041ep559 | Diabetes therapy | ECE2016

Lixisenatide effects on liver function, lipids and blood pressure levels

del Mar Roca-Rodriguez Maria , Piedrola-Maroto Gonzalo , de Fuentes Maria Teresa Muros , Quesada-Charneco Miguel , Maraver-Selfa Silvia , Tapia-Guerrero M Jose , Cepero-Garcia Daniel , Orduna-Espinosa Rosa , Pechuan-Asensio Joaquin , Ferrandiz-Millon Elena , Galera-Martinez Purificacion , Vazquez-Gutierrez Mercedes , Mancha-Doblas Isabel

Introduction: New diabetes treatments, such as lixisenatide, improve global metabolic status beyond glycemic control.Aim: To evaluate lixisenatide effects on liver function, lipids and blood pressure levels in type 2 diabetes and obese patients attended in endocrinology offices.Material and method: This is a prospective study with a sample of 106 patients with type 2 diabetes and obesity. In an intra-subject analysis, clinical and ...

ea0037ep428 | Diabetes (complications & therapy) | ECE2015

Lixisenatide clinical experience on patients with type 2 diabetes and obesity in Endocrinology Offices

Mar Roca-Rodriguez M , de Fuentes Maria Teresa Muros , Piedrola-Maroto Gonzalo , Quesada-Charneco Miguel , Maraver-Selfa Silvia , Tapia-Guerrero M Jose , Cepero-Garcia Daniel , Orduna-Espinosa Rosa , Pechuan-Asensio Joaquin , Ferrandiz-Millon Elena , Galera-Martinez Purificacion , Vazquez-Gutierrez Mercedes , Mancha-Doblas Isabel

Introduction: Some treatments of diabetes, such as lixisenatide, improve global metabolic status beyond glycaemic control.Aim: To evaluate tolerance to lixisenatide and its effects on weight and metabolic control in type 2 diabetes and obese patients attended in Endocrinology Offices.Material and method: A prospective study of patients with type 2 diabetes and obesity. In an intra-subject analysis, clinical and analytical data were...